Azure DevOps Server Cross-Site Scripting Vulnerability
CVE-2023-21564

7.1HIGH

Key Information:

Vendor

Microsoft
Status
Azure Devops Server 2022
Vendor
CVE Published:
14 February 2023

What is CVE-2023-21564?

A cross-site scripting vulnerability in Azure DevOps Server allows attackers to execute malicious scripts in the context of users' browsers. This can lead to unauthorized access to sensitive information and the potential for further compromise of affected systems. Proper user input validation and output encoding measures are critical to mitigate this risk. Microsoft has provided updates to address this issue; users are encouraged to apply these patches to safeguard their environments.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Azure DevOps Server 2022 Unknown 20230131.0 < 20230131.1

References

https://msrc.microsoft.com/update-guide/vulnerability/CVE...
vendor-advisory

EPSS Score

6% chance of being exploited in the next 30 days.

CVSS V3.1

Score:
7.1
Severity:
HIGH
Confidentiality:
High
Integrity:
Low
Availability:
High
Attack Vector:
Network
Attack Complexity:
Low
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.